Accepting PhD Students

  • 3510 Citations
  • 35 h-Index
1987 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Google Scholar h-Index

40 Last updated 22 June 2020

Biography

Professor Roger Phillips was appointed Professor of Cancer Pharmacology in July 2014.

Following a BSc in Marine Biology and Biochemistry (Joint Honours) from University College of North Wales, Bangor, Roger specialised in Cancer Pharmacology gaining his PhD in 1988 from the University of Bradford (under Profs John Double and Mike Bibby). After an initial postdoctoral position in Bradford, he moved to the School of Pharmacy, University of Southern California, Los Angeles to work with Dr Neil Gibson in 1991. He returned to Bradford in 1993 and secured academic appointments as lecturer (1996 to 2001), Senior Lecturer (2001 to 2003) and Reader (2003 to 1014) in Cancer Pharmacology. In July 2014, Roger was appointed as Professor of Cancer Pharmacology at the University of Huddersfield. He was also appointed as Director of Research in the School of Applied Sciences in August 2015.

His research focuses on the preclinical and early clinical evaluation of novel anti-cancer drugs with a specific interest in the tumour microenvironment as a target for drug development. His research has had clinical impact through the development of EO9 as a therapeutic drug for the treatment of superficial bladder cancer. He has published extensively in internationally recognised journals, has successfully supervised over 20 PhD students and continues to present his work at national and international conferences. He is a committee member of the European Organisation for the Research and Treatment of Cancer (EORTC) Drug Development Committee and the Pharmacology and Molecular Mechanism Group. He is also an editorial board member for the British Journal of Pharmacology. 

Research Expertise and Interests

  • Preclinical development of novel anti-cancer drugs
  • Phenotype based screening
  • Development of experimental models that reflect the complexity of tumour biology
  • The hypoxic tumour microenvironment as a target for drug development
  • Drug delivery to hypoxic regions of solid tumours

Research Degree Supervision

Click Here to see all postgraduate research opportunities with Professor Roger Philips

Research Expertise and Interests

  • Biochemistry
  • Molecular Medicine
  • Cancer Research
  • Drug Development
  • Biomarker Research
  • Pharmaceutics

Fingerprint Dive into the research topics where Roger Phillips is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 3 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

Glycoconjugated Metallohelices have Improved Nuclear Delivery and Suppress Tumour Growth In Vivo

Song, H., Allison, S. J., Brabec, V., Bridgewater, H. E., Kasparkova, J., Kostrhunova, H., Novohradsky, V., Phillips, R. M., Pracharova, J., Rogers, N. J., Shepherd, S. L. & Scott, P., 2 Jun 2020, In : Angewandte Chemie - International Edition. 10 p.

Research output: Contribution to journalArticle

Open Access
  • In-vitro biological evaluation of half sandwich platinum group metal complexes containing benzothiazole moiety

    Shadap, L., Banothu, V., Pinder, E., Phillips, R., Kaminsky, W. & Kollipara, M. R., 12 Jun 2020, In : Journal of Coordination Chemistry.

    Research output: Contribution to journalArticle

  • Revisiting Bromohexitols as a Novel Class of Microenvironment-Activated Prodrugs for Cancer Therapy

    Johansson, H., Hussain, O., Allison, S. J., Robinson, T. V., Phillips, R. & Pedersen, D. S., 17 Jan 2020, In : ChemMedChem. 15, 2, p. 228-235 8 p.

    Research output: Contribution to journalArticle

  • Ru, Rh and Ir metal complexes of pyridyl chalcone derivatives: Their potent antibacterial activity, comparable cytotoxicity potency and selectivity to cisplatin

    Dkhar, L., Banothu, V., Pinder, E., Phillips, R. M., Kaminsky, W. & Kollipara, M. R., 15 Jul 2020, In : Polyhedron. 185, 11 p., 114606.

    Research output: Contribution to journalArticle

  • Silver(I) N‑Heterocyclic Carbene Complexes Derived from Clotrimazole: Antiproliferative Activity and Interaction with an Artificial Membrane-Based Biosensor

    Mohamed, H. A., Shepherd, S., William, N., Blundell, H. A., Das, M., Pask, C. M., Lake, B. R. M., Phillips, R., Nelson, A. & Willans, C. E., 27 Apr 2020, In : Organometallics. 39, 8, p. 1318-1331 14 p.

    Research output: Contribution to journalArticle

  • Activities

    • 7 PhD Examination
    • 4 Invited talk
    • 1 Editorial work
    • 1 Membership of committee

    PhD External Examiner at the Universit Putra Malaysia

    Roger Phillips (Examiner)
    19 Nov 2019

    Activity: Examination typesPhD Examination

    The preclinical and clinical development of Apaziquone - the trials and tribulations of working in drug development

    Roger Phillips (Keynote speaker)
    23 Oct 201925 Oct 2019

    Activity: Talk or presentation typesInvited talk

    PhD External Examination at the University of Leeds

    Roger Phillips (Examiner)
    14 Oct 2019

    Activity: Examination typesPhD Examination

    Targeting the hypoxic fraction of cancer

    Roger Phillips (Speaker)
    10 Oct 2019

    Activity: Talk or presentation typesInvited talk

    File

    Targeted or Phenotypic Approaches to Cancer Drug Discovery

    Roger Phillips (Speaker)
    4 Oct 2019

    Activity: Talk or presentation typesInvited talk